Viibryd Withdrawal and Tapering Help
Viibryd is the trade name for
Vilazodone, a potent dual-acting SSRI Antidepressant, approved by
the FDA in March 2015 to treat major depression. Viibryd Side
Effects include diarrhea, trouble sleeping and nausea, with
serious Viibryd Side Effects including increased suicidal thoughts
or actions, serotonin syndrome, mania, bleeding and SIADH, a
serious condition where excess, unsuppressible release of an
anti-diuretic hormone causing excessive water retention. In order
to mitigate Viibryd Withdrawal Symptoms it is important to Wean
Off Viibryd, yet many find that even a slow Wean Off Viibryd still
causes symptoms that interfere with daily life. Getting Off
Viibryd is possible, and our nonprofit takes a holistic approach
to Taper Off Viibryd. Our program utilizes nutraceuticals to help ease the Viibryd Withdrawals while augment the healing of the
receptors. If you need Help To Get Off Viibryd, Contact our
Experts today.
How the Program and Tapering Process Works Viibryd Dependence
Our Viibryd weaning program is a slow taper that allows you to safely step down from Viibryd under the guidance of Our Team, Your Physician and Pharmacist. The Pre-Taper is for Symptom Relief. You will not wean Viibryd
until you feel better. This is where our Advanced Nutraceuticals are critical. Point of Return provides healthy, Drug-Free Strategies to help ease Viibryd withdrawal and support well-being.*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our In-Home programs are individualized based on your situation. An assessment is done once you start which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; and interactions. Don't Wean Viibryd alone, work with our Prescription Drug Experts.
Imagine being Free of Viibryd Dependency
- Proven Program completed At-Home with Expert Guidance
- Natural Nutraceuticals to help ease Viibryd withdrawal symptoms
- Your program is customized for your specific situation
- Professional information on herb/vitamin/over-the-counter interactions
- 15 years of experience helping people in 78 countries
- Free Expert Mentoring on our 24/7 private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
Learn More about our withdrawal program.
Call toll-free 866-605-2333 to Learn More or send us an Email.
We've helped people in 78 countries and in all 50 states in the USA
PROVEN RESULTS
SIMPLE - NATURAL - SAFE - EFFECTIVE
This experience has left me humbled and oh so grateful. Please let Point of Return work for you. They will provide the tools you need to succeed.
more...
Viibryd In-Home Withdrawal Program
Join our tapering program today!
Break Free Today
At Point of Return, a 501(c)3 nonprofit, we have spent the last 15 years helping people wean off antidepressants correctly. With customized taper rates and all natural nutraceuticals, our program allows you to come off Viibryd, once and for
all, from the comfort of your home.
Read program FAQs
Freedom
" I owe it all to you, and everyone else at Point of Return. Thank you for all your hard work, and your perseverance, and your blood, sweat, and tears. I can promise you, that it is all worth it! I am forever grateful, and I will never stop telling people about Point of Return. more...
Side Effects May Include
Common adverse effects (1-10% incidence)
Vomiting, Dry mouth, Dizziness, Insomnia
Uncommon adverse effects (0.1-1% incidence)
Somnolence, Paraesthesia, Tremor, Abnormal dreams, Libido decreased, Restlessness, Akathisia, Restless legs syndrome, Abnormal orgasms (male patients only), Delayed ejaculations (male patients only),
Erectile dysfunction (male patients only), Fatigue, Feeling jittery, Palpitations, Ventricular premature beats, Arthralgia, Increased appetite
Rare adverse effects (<0.1% incidence)
Serotonin Syndrome - a serious adverse effect characterised by:
Nausea, Vomiting, Mental status change (e.g. confusion, hallucinations, agitation, coma, stupor), Muscle rigidity, Tremor, Myoclonus, Hyperreflexia, Â overresponsive/overactive reflexes, Hyperthermia/elevated
body temperature, Autonomic instability (e.g. tachycardia, dizziness, abnormally excessive sweating, etc.)
Mania/hypomania a potentially dangerously elated/agitated mood. Every antidepressant has the potential to induce these psychiatric reactions. They are particularly problematic in those with a history of hypomania/mania such as those with bipolar disorder
Withdrawal Symptoms May Include
Drowsiness, dizziness, dry mouth, blurred vision, constipation, weight gain, or trouble urinating, myocardial infarction, arrhythmia, hypotension, hypertension, palpitation, tachycardia, coma, seizures,
hallucinations; delusions, confused states; disorientation, incoordination, tremors, peripheral neuropathy, abnormal involuntary movements, tardive dyskinesia, dysarthria, disturbed concentration, anxiety,
insomnia, restlessness, nightmares, drowsiness, dizziness, weakness, fatigue, headache, syndrome of inappropriate ADH secretion, tinnitus, hyperpyrexia, urinary retention, dilation of urinary tract,
constipation, blurred vision, increased ocular pressure, skin rash, urticarial, edema of face and tongue, bone marrow depression, nausea, vomiting, anorexia, stomatitis; peculiar taste, diarrhea, black
tongue, testicular swelling, breast enlargement – female, increased or decreased libido, impotence, elevation and lowering of blood sugar levels, alopecia, weight gain or loss, urinary frequency, increased
perspiration
Other names for Viibryd Include:
Vilazodone
Viibryd history and info
Viibryd, also known as Vilazodone is an Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant that exerts its mechanism of action on Serotonin.
Viibryd should not be combined with MAO Inhibitors, Tramadol, Tryptophan, 5HTP or any supplements that increase Serotonin, or with antipsychotic medications. In addition, the use of Viibryd in combination with other Central Nervous System drugs has not been systematically evaluated. Therefore it is recommended to use caution when combining Viibryd with other agents.
Withdrawal symptoms, known as a Discontinuation Syndrome have been reported with Viibryd. A gradual dose reduction is recommended rather than abrupt discontinuation.
Viibryd received FDA approval in January 2011 after Trovis Pharmaceuticals completed two Phase III eight-week clinical trials.
Viibryd may cause low blood sodium (hyponatremia), with symptoms including headache, confusion, problems concentrating, memory problems, weakness and unsteadiness. The elderly and patients taking diuretics are more at risk for
hyponatremia.
Combining Viibryd with NSAIDs, aspirin, warfarin or other drugs that effect blood coagulation can cause an increased risk of abnormal bleeding.
Viibryd is considered a pregnancy Category C medication, meaning that it may not be safe for use during pregnancy. It is unknown if Viibryd passes through breast milk.
Withdrawal symptoms, known as a Discontinuation Syndrome have been reported with Viibryd. A gradual dose reduction is recommended rather than abrupt discontinuation. Withdrawal symptoms may include anxiety, irritability, insomnia,
diarrhea, tremors, headaches, dizziness and nausea.
--
According to the FDA:
Discontinuation of Treatment with VIIBRYD: A gradual reduction in dose is recommended rather than an abrupt cessation
Discontinuation
Advise patients not to stop taking VIIBRYD without talking first with their healthcare provider. Patients should be aware that discontinuation effects may occur when suddenly stopping VIIBRYD
Discontinuing Treatment
Discontinuation symptoms have been reported with discontinuation of serotonergic drugs such as VIIBRYD. Gradual dose reduction is recommended, instead of abrupt discontinuation, whenever possible. Monitor patients for these symptoms when discontinuing VIIBRYD. If intolerable symptoms occur following a dose decrease or upon discontinuation of treatment, consider resuming the previously prescribed dose and decreasing the dose at a more gradual rate [see Warnings and Precautions
References:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278186/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278186/
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022567s000lbl.pdf
DISCLAIMER:
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized With Your physician to help you with your drug withdrawal process and with his or her consent and support throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the proces. More...